81 related articles for article (PubMed ID: 25939516)
1. Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.
Umbehr MH; Gurel B; Murtola TJ; Sutcliffe S; Peskoe SB; Tangen CM; Goodman PJ; Thompson IM; Lippman SM; Lucia MS; Parnes HL; Drake CG; Nelson WG; De Marzo AM; Platz EA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):264-9. PubMed ID: 25939516
[TBL] [Abstract][Full Text] [Related]
2. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.
Gurel B; Lucia MS; Thompson IM; Goodman PJ; Tangen CM; Kristal AR; Parnes HL; Hoque A; Lippman SM; Sutcliffe S; Peskoe SB; Drake CG; Nelson WG; De Marzo AM; Platz EA
Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):847-56. PubMed ID: 24748218
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen trends and prostate cancer detection on follow-up in men with a prior negative biopsy: A cohort study.
Modi A; Singh P; Seth A; Kumar R
Indian J Urol; 2023; 39(4):292-296. PubMed ID: 38077201
[TBL] [Abstract][Full Text] [Related]
4. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
5. Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators.
Strobl AN; Vickers AJ; Van Calster B; Steyerberg E; Leach RJ; Thompson IM; Ankerst DP
J Biomed Inform; 2015 Aug; 56():87-93. PubMed ID: 25989018
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine (PhIP)-Induced Cancer at Multiple Sites.
Sfanos KS; Canene-Adams K; Hempel H; Yu SH; Simons BW; Schaeffer AJ; Schaeffer EM; Nelson WG; De Marzo AM
Cancer Prev Res (Phila); 2015 Aug; 8(8):683-92. PubMed ID: 25990088
[TBL] [Abstract][Full Text] [Related]
7. Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Chau CH; Price DK; Till C; Goodman PJ; Chen X; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Tangen CM; Chu L; Parnes HL; Schenk JM; Reichardt JK; Thompson IM; Figg WD
PLoS One; 2015; 10(5):e0126672. PubMed ID: 25955319
[TBL] [Abstract][Full Text] [Related]
8. Two susceptibility loci identified for prostate cancer aggressiveness.
Berndt SI; Wang Z; Yeager M; Alavanja MC; Albanes D; Amundadottir L; Andriole G; Beane Freeman L; Campa D; Cancel-Tassin G; Canzian F; Cornu JN; Cussenot O; Diver WR; Gapstur SM; Grönberg H; Haiman CA; Henderson B; Hutchinson A; Hunter DJ; Key TJ; Kolb S; Koutros S; Kraft P; Le Marchand L; Lindström S; Machiela MJ; Ostrander EA; Riboli E; Schumacher F; Siddiq A; Stanford JL; Stevens VL; Travis RC; Tsilidis KK; Virtamo J; Weinstein S; Wilkund F; Xu J; Lilly Zheng S; Yu K; Wheeler W; Zhang H; ; Sampson J; Black A; Jacobs K; Hoover RN; Tucker M; Chanock SJ
Nat Commun; 2015 May; 6():6889. PubMed ID: 25939597
[TBL] [Abstract][Full Text] [Related]
9. Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.
Kantor ED; Lipworth L; Fowke JH; Giovannucci EL; Mucci LA; Signorello LB
Prostate; 2015 Sep; 75(13):1384-93. PubMed ID: 26012482
[TBL] [Abstract][Full Text] [Related]
10. Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer?
Dorff TB; Gross ME
Am Soc Clin Oncol Educ Book; 2015; ():e270-3. PubMed ID: 25993185
[TBL] [Abstract][Full Text] [Related]
11. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.
Haffner MC; Weier C; Xu MM; Vaghasia A; Gürel B; Gümüşkaya B; Esopi DM; Fedor H; Tan HL; Kulac I; Hicks J; Isaacs WB; Lotan TL; Nelson WG; Yegnasubramanian S; De Marzo AM
J Pathol; 2016 Jan; 238(1):31-41. PubMed ID: 26331372
[TBL] [Abstract][Full Text] [Related]
13. Spatial genomic heterogeneity within localized, multifocal prostate cancer.
Boutros PC; Fraser M; Harding NJ; de Borja R; Trudel D; Lalonde E; Meng A; Hennings-Yeomans PH; McPherson A; Sabelnykova VY; Zia A; Fox NS; Livingstone J; Shiah YJ; Wang J; Beck TA; Have CL; Chong T; Sam M; Johns J; Timms L; Buchner N; Wong A; Watson JD; Simmons TT; P'ng C; Zafarana G; Nguyen F; Luo X; Chu KC; Prokopec SD; Sykes J; Dal Pra A; Berlin A; Brown A; Chan-Seng-Yue MA; Yousif F; Denroche RE; Chong LC; Chen GM; Jung E; Fung C; Starmans MH; Chen H; Govind SK; Hawley J; D'Costa A; Pintilie M; Waggott D; Hach F; Lambin P; Muthuswamy LB; Cooper C; Eeles R; Neal D; Tetu B; Sahinalp C; Stein LD; Fleshner N; Shah SP; Collins CC; Hudson TJ; McPherson JD; van der Kwast T; Bristow RG
Nat Genet; 2015 Jul; 47(7):736-45. PubMed ID: 26005866
[TBL] [Abstract][Full Text] [Related]
14. Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab.
Kwek SS; Lewis J; Zhang L; Weinberg V; Greaney SK; Harzstark AL; Lin AM; Ryan CJ; Small EJ; Fong L
Cancer Immunol Res; 2015 Sep; 3(9):1008-16. PubMed ID: 25968455
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells in Biochemical Recurrence of Prostate Cancer.
Aragon-Ching JB; Siegel RS; Frazier H; Andrawis R; Hendricks F; Phillips M; Jarrett T; Guebre-Xabiher H; Patierno S; Simmens SJ
Clin Genitourin Cancer; 2015 Oct; 13(5):e341-5. PubMed ID: 25956468
[TBL] [Abstract][Full Text] [Related]
16. Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer.
Renard-Penna R; Cancel-Tassin G; Comperat E; Roupret M; Mozer P; Cussenot O
World J Urol; 2015 Jul; 33(7):929-36. PubMed ID: 25944677
[TBL] [Abstract][Full Text] [Related]
17. Survivorship and improving quality of life in men with prostate cancer.
Bourke L; Boorjian SA; Briganti A; Klotz L; Mucci L; Resnick MJ; Rosario DJ; Skolarus TA; Penson DF
Eur Urol; 2015 Sep; 68(3):374-83. PubMed ID: 25941049
[TBL] [Abstract][Full Text] [Related]
18. Serial blood-based analysis of AR-V7 in men with advanced prostate cancer.
Nakazawa M; Lu C; Chen Y; Paller CJ; Carducci MA; Eisenberger MA; Luo J; Antonarakis ES
Ann Oncol; 2015 Sep; 26(9):1859-1865. PubMed ID: 26117829
[TBL] [Abstract][Full Text] [Related]
19. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
[TBL] [Abstract][Full Text] [Related]
20. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
